Skip to main content
SpringerLink
Log in

Health-related quality of life aspects in patients with low-grade glioma

  • Chapter
Low-Grade Gliomas

Part of the book series: Advances and Technical Standards in Neurosurgery ((NEUROSURGERY,volume 35))

Abstract

Standard therapeutic options for brain tumors include surgery, radiotherapy, and chemotherapy. Unfortunately, these same therapies pose risks of neurotoxicity, the most common long-term complications being radiation necrosis, chemotherapy-associated leukoencephalopathy, and cognitive deficits. Currently, there is no consensus on the treatment strategy for these tumors. Because of the relatively slow growth rate of low-grade gliomas, patients have a relatively long expected survival.

Compared to traditional outcome measures like (progression-free) survival, evaluation of health-related quality of life may be time-consuming and burdensome for both the patient and the doctor. Besides, given the relatively low incidence of brain tumors and the ultimately fatal outcome of the disease, the interest in HRQOL emerged relatively late in these patients. Moreover, the notion that the disease itself may affect the patient’s ability to judge his or her own functioning may hinder the use of patient self-reported measures.

In future trials, more sensitive measures of long-term cognitive, functional, and HRQOL outcomes on LGG patients at important time points over the disease trajectory are needed to better understand the changing needs that take place over time.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson NK, Bakker W, Stewart AL, van Dam FSAM, van Zandwijk N, Yarnold JR, et al. (1987) Multi-dimensional approach to the measurement of quality of life in lung cancer clinical trials. In: Aaronson NK, Beckmann J (eds) The quality of life of cancer patients. Raven Press, New York

    Google Scholar 

  2. Aaronson NK, Cull A, Kaasa S, Spangers M (1985) The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology. Int J Mental Health 23(2): 75–106

    Google Scholar 

  3. Aaronson NK, Muller MJ, Klein M, Heimans JJ, Van der Ploeg HM, Postma TJ, et al. (2008) Compromised health-related quality of life among long-term survivors of low-grade glioma. (submitted)

    Google Scholar 

  4. Anderson SI, Taylor R, Whittle IR (1999) Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg 13(5): 480–85

    PubMed  CAS  Google Scholar 

  5. Anderson SW, Damasio H, Tranel D (1990) Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol 47(4): 397–405

    PubMed  CAS  Google Scholar 

  6. Andrewes DG, Kaye A, Murphy M, Harris B, Aitken S, Parr C, et al. (2003) Emotional and social dysfunction in patients following surgical treatment for brain tumour. J Clin Neurosci 10(4): 428–33

    Article  PubMed  Google Scholar 

  7. Arlt W, Hove U, Muller B, Reincke M, Berweiler U, Schwab F, et al. (1997) Frequent and frequently overlooked: treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors. Neurology 49(2): 498–506

    PubMed  CAS  Google Scholar 

  8. Béhin A, Delattre JY (2003) Neurologic sequelae of radiotherapy of the nervous system. In: Schiff D, Wen PY (eds) Cancer neurology in clinical practice. Humana Press, Totowa, pp 173–92

    Google Scholar 

  9. Bergner M, Bobbitt RA, Carter WB, Gilson BS (1981) The sickness impact profile: development and final revision of a health status measure. Med Care 19(8): 787–805

    Article  PubMed  CAS  Google Scholar 

  10. Brada M, Viviers L, Abson C, Hines F, Britton J, Ashley S, et al. (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14(12): 1715–21

    Article  PubMed  CAS  Google Scholar 

  11. Brown PD, Buckner JC, O’Fallon JR, Iturria NL, Brown CA, O’Neill BP, et al. (2003) Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol 21(13): 2519–24

    Article  PubMed  Google Scholar 

  12. Cairncross JG, Laperriere NJ (1989) Low-grade glioma. To treat or not to treat? Arch Neurol 46(11): 1238–39

    PubMed  CAS  Google Scholar 

  13. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, et al. (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90(19): 1473–79

    Article  PubMed  CAS  Google Scholar 

  14. Calman KC (1984) Quality of life in cancer patients — an hypothesis. J Med Ethics 10(3): 124–27

    Article  PubMed  CAS  Google Scholar 

  15. Cella DF, Tulsky DS (1990) Measuring quality of life today: methodological aspects. Oncology (Williston Park) 4(5): 29–38; discussion 69

    CAS  Google Scholar 

  16. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3): 570–79

    PubMed  CAS  Google Scholar 

  17. Coates A, Gebski V, Bishop JF, Jeal PN, Woods RL, Snyder R, et al. (1987) Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med 317(24): 1490–95

    PubMed  CAS  Google Scholar 

  18. Costello A, Shallice T, Gullan R, Beaney R (2004) The early effects of radiotherapy on intellectual and cognitive functioning in patients with frontal brain tumours: the use of a new neuropsychological methodology. J Neurooncol 67(3): 351–59

    Article  PubMed  Google Scholar 

  19. Crossen JR, Garwood D, Glatstein E, Neuwelt EA (1994) Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12: 627–42

    PubMed  CAS  Google Scholar 

  20. Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M (1996) What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer 74: 1674–79

    PubMed  CAS  Google Scholar 

  21. Derogatis LR, Lopez MC (1983) The psychosocial adjustment to illness scale: administration, scoring and procedures manual-I. Clinical Psychometric Research, Baltimore

    Google Scholar 

  22. Dimond S (1980) Neuropsychology: a textbook of systems and psychological functions of the human brain. Butterworth, London

    Google Scholar 

  23. Drane LD, Meador KJ (2002) Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 3(5S): 49–53

    Article  PubMed  Google Scholar 

  24. Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Lopes M, et al. (2003) Functional recovery after surgical resection of low-grade gliomas in eloquent brain: hypothesis of brain compensation. J Neurol Neurosurg Psychiatry 74(7): 901–07

    Article  PubMed  CAS  Google Scholar 

  25. Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Taillandier L, et al. (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg 98(4): 764–78

    Article  PubMed  Google Scholar 

  26. Falleti MG, Maruff P, Burman P, Harris A (2006) The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology 31(6): 681–91

    Article  PubMed  CAS  Google Scholar 

  27. Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17 (3 Suppl): 15–19; discussion 20–11

    PubMed  CAS  Google Scholar 

  28. Ferrell BR, Hassey Dow K (1997) Quality of life among long-term cancer survivors. Oncology (Williston Park) 11(4): 565–68

    CAS  Google Scholar 

  29. Gelber RD, Goldhirsch A (1986) A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 4(12): 1772–79

    PubMed  CAS  Google Scholar 

  30. Giovagnoli AR, Tamburini M, Boiardi A (1996) Quality of life in brain tumor patients. J Neurooncol 30(1): 71–80

    Article  PubMed  CAS  Google Scholar 

  31. Goldhirsch A, Gelber RD, Simes RJ, Glasziou P, Coates AS (1989) Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. J Clin Oncol 7(1): 36–44

    PubMed  CAS  Google Scholar 

  32. Grassi L, Indelli M, Marzola M, Maestri A, Santini A, Piva E, et al. (1996) Depressive symptoms and quality of life in home-care-assisted cancer patients. J Pain Symptom Manage 12(5): 300–07

    Article  PubMed  CAS  Google Scholar 

  33. Gustafsson M, Edvardsson T, Ahlstrom G (2006) The relationship between function, quality of life and coping in patients with low-grade gliomas. Support Care Cancer 14(12): 1205–12

    Article  PubMed  Google Scholar 

  34. Guthrie BL, Laws ER Jr (1990) Supratentorial low-grade gliomas. Neurosurg Clin North Am 1(1): 37–48

    CAS  Google Scholar 

  35. Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55(4): 992–99

    PubMed  CAS  Google Scholar 

  36. Hall RC, Popkin MK, Stickney SK, Gardner ER (1979) Presentation of the steroid psychoses. J Nerv Ment Dis 167(4): 229–36

    Article  PubMed  CAS  Google Scholar 

  37. Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Selker RG, Fine HA, et al. (2003) Laterality of brain tumors. Neuroepidemiology 22(2): 130–38

    Article  Google Scholar 

  38. Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, et al. (2007) Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 68(21): 1831–36

    Article  PubMed  CAS  Google Scholar 

  39. Karnofsky DA, Abelmann WH, Craver LF (1948) The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1: 634–56

    Article  Google Scholar 

  40. Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205

    Google Scholar 

  41. Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT (1996) The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 47(6): 1396–402

    PubMed  CAS  Google Scholar 

  42. Keime-Guibert F, Napolitano M, Delattre JY (1998) Neurological complications of radiotherapy and chemotherapy. J Neurol 245: 695–708

    Article  PubMed  CAS  Google Scholar 

  43. Kiebert GM, Curran D, Aaronson NK, Bolla M, Menten J, Rutten EH, et al. (1998) Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer 34(12): 1902–09

    Article  PubMed  CAS  Google Scholar 

  44. Klein M, Engelberts NHJ, Van der Ploeg HM, Kasteleijn-Nolst Trenité DGA, Aaronson NK, Taphoorn MJB, et al. (2003) Epilepsy in low-grade gliomas: the impact on cognitive functioning and quality of life. Ann Neurol 54(4): 514–20

    Article  PubMed  Google Scholar 

  45. Klein M, Heimans JJ, Aaronson NK, van der Ploeg HM, Grit J, Muller M, et al. (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360(9343): 1361–68

    Article  PubMed  CAS  Google Scholar 

  46. Kornblith AB, Holland JC (1996) Model for quality-of-life research from the Cancer and Leukemia Group B: the telephone interview, conceptual approach to measurement, and theoretical framework. J Natl Cancer Inst Monogr (20): 55–62

    PubMed  Google Scholar 

  47. Laack NN, Brown PD, Ivnik RJ, Furth AF, Ballman KV, Hammack JE, et al. (2005) Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys 63(4): 1175–83

    PubMed  Google Scholar 

  48. Lazarus RS, Folkman S (1984) Stress, appraisal and coping. Springer, Berlin, Heidelberg, New York

    Google Scholar 

  49. Lebrun C, Fontaine D, Bourg V, Ramaioli A, Chanalet S, Vandenbos F, et al. (2007) Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. Eur J Neurol 14(4): 391–98

    Article  PubMed  CAS  Google Scholar 

  50. Lebrun C, Fontaine D, Ramaioli A, Vandenbos F, Chanalet S, Lonjon M, et al. (2004) Longterm outcome of oligodendrogliomas. Neurology 62(10): 1783–87

    PubMed  CAS  Google Scholar 

  51. Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, et al. (1997) Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 15(4): 1294–301

    PubMed  CAS  Google Scholar 

  52. Lilja A, Hagstadius S, Risberg J, Salford LG, Smith GJW, Ohman R (1992) Frontal lobe dynamics in brain tumor patients: a study of regional blood flow and affective changes before and after surgery. Neuropsychiatry Neuropsychol Behav Neurol 5: 294–300

    Google Scholar 

  53. Lopes MB, Laws ER Jr (2002) Low-grade central nervous system tumors. Neurosurg Focus 12(2): E1

    Article  Google Scholar 

  54. Mackworth N, Fobair P, Prados MD (1992) Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neurooncol 14(3): 243–53

    Article  PubMed  CAS  Google Scholar 

  55. Mainio A, Tuunanen S, Hakko H, Niemela A, Koivukangas J, Rasanen P (2006) Decreased quality of life and depression as predictors for shorter survival among patients with lowgrade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci 256(8): 516–21

    Article  PubMed  Google Scholar 

  56. Mandonnet E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, et al. (2003) Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 53(4): 524–28

    Article  PubMed  Google Scholar 

  57. Mason WP, Krol GS, De Angelis LM (1996) Low-grade oligodendroglioma responds to chemotherapy. Neurology 46(1): 203–07

    PubMed  CAS  Google Scholar 

  58. Meador KJ (2006) Cognitive and memory effects of the new antiepileptic drugs. Epilepsy Res 68(1): 63–67

    Article  PubMed  Google Scholar 

  59. Meador KJ, Gevins A, Loring DW, McEvoy LK, Ray PG, Smith ME, et al. (2007) Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. Neurology 69(22): 2076–84

    Article  PubMed  CAS  Google Scholar 

  60. Meyers CA, Berman SA, Scheibel RS, Hayman A (1992) Case report: acquired antisocial personality disorder associated with unilateral left orbital frontal lobe damage. J Psychiatry Neurosci 17(3): 121–25

    PubMed  CAS  Google Scholar 

  61. Olson JD, Riedel E, De Angelis LM (2000) Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54(7): 1442–48

    PubMed  CAS  Google Scholar 

  62. Pace A, Vidiri A, Galie E, Carosi M, Telera S, Cianciulli AM, et al. (2003) Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol 14(12): 1722–26

    Article  PubMed  CAS  Google Scholar 

  63. Packer RJ, Mehta M (2002) Neurocognitive sequelae of cancer treatment. Neurology 59(1): 8–10

    PubMed  Google Scholar 

  64. Pahlson A, Ek L, Ahlstrom G, Smits A (2003) Pitfalls in the assessment of disability in individuals with low-grade gliomas. J Neurooncol 65(2): 149–58

    Article  PubMed  Google Scholar 

  65. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, et al. (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20(8): 2076–84

    Article  PubMed  Google Scholar 

  66. Popper KR, Eccles JC (1977) The self and its brain. Springer, Berlin, Heidelberg

    Google Scholar 

  67. Pouratian N, Gasco J, Sherman JH, Shaffrey ME, Schiff D (2007) Toxicity and efficacy of protracted low dose temozolomide for the treatment of low-grade gliomas. J Neurooncol 82(3): 281–88

    Article  PubMed  CAS  Google Scholar 

  68. Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13(1): 46–51

    Article  PubMed  CAS  Google Scholar 

  69. Recht LD, Lew R, Smith TW (1992) Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31: 431–36

    Article  PubMed  CAS  Google Scholar 

  70. Reijneveld JC, Sitskoorn MM, Klein M, Nuyen J, Taphoorn MJB (2001) Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas. Neurology 56(5): 618–23

    PubMed  CAS  Google Scholar 

  71. Ricard D, Kaloshi G, Amiel-Benouaich A, Lejeune J, Marie Y, Mandonnet E, et al. (2007) Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol 61(5): 484–90

    Article  PubMed  CAS  Google Scholar 

  72. Sachsenheimer W, Piotrowski W, Bimmler T (1992) Quality of life in patients with intracranial tumors on the basis of Karnofsky’s performance status. J Neurooncol 13(2): 177–81

    Article  PubMed  CAS  Google Scholar 

  73. Salo J, Niemela A, Joukamaa M, Koivukangas J (2002) Effect of brain tumour laterality on patients’ perceived quality of life. J Neurol Neurosurg Psychiatry 72(3): 373–77

    Article  PubMed  CAS  Google Scholar 

  74. Schag CA, Ganz PA, Heinrich RL (1991) Cancer Rehabilitation Evaluation System-Short Form (CARES-SF). A cancer specific rehabilitation and quality of life instrument. Cancer 68(6): 1406–13

    Article  PubMed  CAS  Google Scholar 

  75. Scheibel RS, Meyers CA, Levin VA (1996) Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol 30(1): 61–69

    Article  PubMed  CAS  Google Scholar 

  76. Schipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J Clin Oncol 2(5): 472–83

    PubMed  CAS  Google Scholar 

  77. Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33(5): 328–36

    Article  PubMed  CAS  Google Scholar 

  78. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM (1988) Who should measure quality of life, the doctor or the patient? Br J Cancer 57(1): 109–12

    PubMed  CAS  Google Scholar 

  79. Spielberger C, Gorsuch R, Lushene R (1970) Manual for the state-trait anxiety inventory. Consulting Psychologist Press, Palo Alto, California

    Google Scholar 

  80. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, et al. (1981) Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis 34(12): 585–97

    Article  PubMed  CAS  Google Scholar 

  81. Stewart AL, Hays RD, Ware JE Jr (1988) The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 26(7): 724–35

    Article  PubMed  CAS  Google Scholar 

  82. Stewart AL, Ware, JE (eds) (1992) Measuring functioning and well-being: the medical outcomes study approach. Duke University Press, Durham, NC

    Google Scholar 

  83. Struik K, Klein M, Heimans JJ, Gielissen MF, Blijenberg G, Taphoorn MJB, et al. (2009) Fatigue in low-grade glioma. J Neurooncol 27(22): 3712–22

    Google Scholar 

  84. Surma-aho O, Niemela M, Vilkki J, Kouri M, Brander A, Salonen O, et al. (2001) Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56(10): 1285–90

    PubMed  CAS  Google Scholar 

  85. Taphoorn MJB, Heimans JJ, Snoek FJ, Lindeboom J, Oosterink B, Wolbers JG, et al. (1992) Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 55(5): 372–76

    Article  PubMed  CAS  Google Scholar 

  86. Taphoorn MJB, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurology 3(3): 159–68

    Article  PubMed  Google Scholar 

  87. Taphoorn MJB, Schiphorst AK, Snoek FJ, Lindeboom J, Wolbers JG, Karim AB, et al. (1994) Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36(1): 48–54

    Article  PubMed  CAS  Google Scholar 

  88. Trojanowski T, Peszynski J, Turowski K, Markiewicz P, Goscinski I, Bielawski A, et al. (1989) Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg 70(1): 18–23

    Article  PubMed  CAS  Google Scholar 

  89. van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurology 6(5): 421–30

    Article  PubMed  Google Scholar 

  90. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C (1998) Supratentorial low-grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 64(5): 581–87

    Article  PubMed  Google Scholar 

  91. Weitzner MA, Meyers CA, Byrne K (1996) Psychosocial functioning and quality of life in patients with primary brain tumors. J Neurosurg 84(1): 29–34

    Article  PubMed  CAS  Google Scholar 

  92. Wen PY (2003) Central nervous system complications of cancer therapy. In: Schiff D, Wen PY (eds) Cancer neurology in clinical practice. Humana Press, Totowa, 21531 pp

    Google Scholar 

  93. Wessels PH, Weber WE, Raven G, Ramaekers FC, Hopman AH, Twijnstra A (2003) Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol 2(7): 395–403

    Article  PubMed  Google Scholar 

  94. Witte OW (1998) Lesion-induced plasticity as a potential mechanism for recovery and rehabilitative training. Curr Opin Neurol 11(6): 655–62

    Article  PubMed  CAS  Google Scholar 

  95. Yeh SA, Lee TC, Chen HJ, Lui CC, Sun LM, Wang CJ, et al. (2002) Treatment outcomes and prognostic factors of patients with supratentorial low-grade oligodendroglioma. Int J Radiat Oncol Biol Phys 54(5): 1405–09

    PubMed  Google Scholar 

  96. Zung WW (1965) A self-rating depression scale. Arch Gen Psychiatry 12: 63–70

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Psychology, VU University Medical Center, Amsterdam, The Netherlands

    M. Klein

Authors
  1. M. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

J. Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag/Wien

About this chapter

Cite this chapter

Klein, M. (2010). Health-related quality of life aspects in patients with low-grade glioma. In: Schramm, J. (eds) Low-Grade Gliomas. Advances and Technical Standards in Neurosurgery, vol 35. Springer, Vienna. https://doi.org/10.1007/978-3-211-99481-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-99481-8_8

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-99480-1

  • Online ISBN: 978-3-211-99481-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation